MarketCap
Facebook
X
Telegram
CEL-SCI Corporation EV/EBITDA Ratio | CVM
Annual EV/EBITDA Ratio CEL-SCI Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.928 | -0.424 | -4.79 | -2.53 | -5.22 | -15.2 | -10.9 | -2.39 | -0.555 | -1.03 | -1.15 | -1.21 | -1.36 | -5.34 | -4.7 | -42.8 K | -23.3 K | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.424 | -42.8 K | -3.89 K |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
OncoCyte Corporation
OCX
|
-0.933 | - | 17.22 % | $ 355 K |  USA |
 |
Onconova Therapeutics
ONTX
|
-0.417 | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
-1.34 | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
-2.28 | $ 8.74 | 0.52 % | $ 606 M | USA |
 |
BiomX
PHGE
|
-0.109 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
0.684 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-2.06 | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
0.144 | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
1.46 | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-2.89 | - | -6.08 % | $ 184 M |  China |
 |
Cassava Sciences
SAVA
|
-0.543 | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
-2.11 | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
-1.19 | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
0.44 | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-1.23 | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
0.0646 | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-0.409 | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
3.66 | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-0.313 | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
0.465 | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
29.7 | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
29 | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
0.101 | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
-1.13 | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-3.12 | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
1.79 K | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
0.05 | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
0.0696 | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
0.657 | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
-1.01 | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
-0.0814 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
0.477 | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-24.2 | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
-0.5 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
-1.5 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
-10.5 | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
0.534 | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
-3.14 | $ 4.2 | -0.71 % | $ 651 M | USA |
 |
AbbVie
ABBV
|
24.9 | $ 293.87 | 0.19 % | $ 520 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
77.8 | $ 151.6 | -3.2 % | $ 19.9 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
-41 | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Avenue Therapeutics
ATXI
|
0.57 | - | -52.27 % | $ 4.45 M | USA |
 |
Axon Enterprise
AXON
|
1.57 K | $ 302.6 | -0.19 % | $ 23.6 B | USA |
 |
Theratechnologies
THTX
|
17 | - | - | $ 83.9 M | Canada |
 |
Liquidia Corporation
LQDA
|
-61 | $ 51.37 | 7.31 % | $ 4.42 B | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-6.79 | $ 45.05 | -9.97 % | $ 4.05 B |  Schweiz |